Corposys SRL
Corposys reported total assets of 23,446 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jul 2026).
The score of Corposys shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -7 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Corposys's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Corposys's financial analysis
- Solvency85.4%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Corposys
Corposys's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0515.962.301
- VAT number
- BE0515962301
- Peppol
- Registered · 0208:0515962301 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Feb 2013
- Registered office
- 4800 Verviers
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Corposys (SRL) has been based in Verviers since 2013, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 366 € and equity of 20,021 €; its revenue is not published. Its solvency stands at 85.4%, above the median of its sector (43.9%).
Companies similar to Corposys
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Bvpm Distribution Andenne · balance sheet 20,739 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Fremed Wholesale of pharmaceutical and medical goods Kortrijk · balance sheet 21,724 €
Frequently asked questions about Corposys
What is the revenue of Corposys?
Corposys files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Corposys?
In Belgium, the VAT number is the company number prefixed with BE: BE0515962301 for Corposys, if the company is VAT-registered. Its company number (CBE) is 0515.962.301.
Where is the registered office of Corposys?
According to the CBE register, the registered office of Corposys is in 4800 Verviers.
What is the equity of Corposys?
At the close of the 2025 financial year, the equity of Corposys amounts to 20,021 €, a solvency of 85.4% of total assets.
Who manages Corposys?
The register lists 1 active mandates at Corposys. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Corposys
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →